Fate Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.

CEO

J. Scott Wolchko

CEOJ. Scott Wolchko

Employees

181

Employees181

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2007

Founded2007

Employees

181

Employees181

FATE Key Statistics

Market cap

445.02M

Market cap445.02M

Price-Earnings ratio

-2.63

Price-Earnings ratio-2.63

Dividend yield

—

Dividend yield—

Average volume

2.41M

Average volume2.41M

High today

$4.40

High today$4.40

Low today

$3.78

Low today$3.78

Open price

$4.18

Open price$4.18

Volume

1.93M

Volume1.93M

52 Week high

$8.83

52 Week high$8.83

52 Week low

$1.63

52 Week low$1.63

FATE News

Simply Wall St 2d

Fate Therapeutics, Inc.'s 28% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St

Fate Therapeutics, Inc. ( ) shares have retraced a considerable 28% in the last month, reversing a fair amount of their solid recent performance. Instead of bei...

Analyst ratings

67%

of 18 ratings

Buy

27.8%

Hold

66.7%

Sell

5.6%